Levalox

Levofloxacin, the active ingredient in Levalox, is a fluoroquinolone presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults and children when prescribed by a healthcare professional, offering coverage for respiratory, urinary and skin infections. The medication works by inhibiting bacterial DNA replication, providing broad‑spectrum activity against Gram‑negative and some Gram‑positive organisms.

GNH USA supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Levofloxacin is a fluoroquinolone antibiotic that interferes with bacterial DNA synthesis, making it effective for several infection types. - Community‑acquired bacterial pneumonia: eradicates common respiratory pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces symptom duration and bacterial load in the sinuses. - Uncomplicated urinary tract infection: eliminates causative uropathogens and relieves urinary symptoms. - Skin and soft‑tissue infections: treats susceptible Gram‑negative and Gram‑positive bacteria causing cellulitis or wound infections.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Nausea: mild stomach upset often occurring after dosing. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or imbalance. - Insomnia: difficulty falling or staying asleep. - Abdominal pain: cramping or discomfort in the stomach area. Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT interval prolongation: cardiac rhythm disturbances that may lead to arrhythmia. - Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate care. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Peripheral neuropathy: numbness or tingling in extremities. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Levofloxacin, clinicians should consider several safety precautions to minimize risks. - Assess renal function: adjust dosage in patients with impaired kidney function. - Avoid use in patients with known tendon disorders: increased risk of tendon rupture. - Monitor cardiac status: caution in patients with prolonged QT interval or taking other QT‑prolonging drugs. - Use with caution in pregnancy or breastfeeding: limited safety data, weigh benefits against risks. - Discontinue if severe hypersensitivity occurs: stop treatment at first sign of allergic reaction. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levofloxacin can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Antacids containing aluminum or magnesium: significantly reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Theophylline: levofloxacin can raise theophylline plasma levels, risking toxicity. - Cyclosporine: concurrent use may increase cyclosporine concentrations. Moderate Interactions (Monitor Closely): - NSAIDs: combined use may enhance central nervous system side effects. - Corticosteroids: concurrent therapy may raise the risk of tendon rupture. - Diabetes medications: levofloxacin may affect blood glucose control.